Women-Led Innovations in Omega-3 Research: Advancing Women’s Health Across Life Stages

In 2024, Women In Nutraceuticals (WIN) reported a striking gender gap in the natural products industry: only one-third of senior managers are female, and just over a quarter of companies are women-led. Yet, paradoxically, one of the fastest-growing sectors within nutraceuticals is products tailored to women's health and wellness across life stages. Nutrition Insight noted in 2023 that supplements marketed for women's health are growing at 40% annually. This disconnect highlights a critical need: greater investment in female-specific research and innovation to address women's unique biological needs, which differ markedly from men's-from fertility and pregnancy to menopause and beyond.

As UK nutritionist Pauline Cox MSc emphasizes, relying on a "male default model" fails to account for the complexities of female biology, including differences in hormonal systems, pain pathways, and disease risk. "Better female-specific research," she argues, "can finally address the millions of women whose health concerns have been misdiagnosed or ignored." This truth is particularly evident in omega-3 lipid metabolism: women, especially pregnant women, metabolize omega-3 precursors more efficiently than men, and during pregnancy, they require increased DHA to support fetal brain development and reduce preterm birth risk.

Pioneering women researchers have been at the forefront of uncovering these gender-specific dynamics. Canadian professor Sheila Innis (d. 2016) revolutionized understanding of dietary fats, demonstrating their impact on maternal health, breast milk fatty acid composition, and infant neurocognitive development-work that reshaped global dietary guidelines. Similarly, Kansas University's Susan Carlson led pivotal randomized trials confirming DHA's conditional essentiality during pregnancy and infancy, paving the way for its inclusion in infant formula starting in 2002. "DHA matters most during these life stages," she noted in 2022, "with benefits spanning preterm birth prevention, visual acuity, and cognitive development."

Australian researcher Maria Makrides addressed a critical gap: preterm infants (<34 weeks) miss the third-trimester surge in placental DHA transfer, when the fetal brain develops rapidly. Her work led to reformulations of infant formula and IV feeding solutions in 180 countries, improving neurocognitive outcomes for millions of premature babies. Meanwhile, Dr. Christina Valentine, a neonatologist and dietitian, bridged industry and clinical practice, enhancing maternal gestation and preterm infant health through omega-3 fortification in dietary, enteral, and parenteral applications.

Harvard's Dr. Emily Oken, through Project Viva, has explored long-term links between early-life omega-3 nutrition (including fish consumption) and health outcomes for mothers and children, highlighting how prenatal behaviors influence lifelong disease risk. "Health is shaped not just by adult choices," she observes, "but by factors starting in utero."

Beyond pregnancy, women researchers are unraveling omega-3s' roles in inflammation, hormonal balance, and age-related health. At the University of Bordeaux, Sophie Layé's Food4BrainHealth consortium investigates how omega-3s protect against neuroinflammation and cognitive decline-critical for women, who are disproportionately affected by Alzheimer's disease. Cardiff University's Valerie O'Donnell, a lipidomics expert, leads efforts to map lipids' roles in vascular health, wound healing, and inflammation via the global LIPID MAPS database. Anna Nicolaou at the University of Manchester focuses on omega-3 metabolites in skin and reproductive system inflammation, while Penny Kris-Etherton's decades of work at Penn State have shaped cardiovascular disease prevention guidelines using omega-3s.

A new generation of female researchers is building on this legacy. Shivtia Trop-Steinberg explores omega-3s and fertility; Kristina Jackson identifies fatty acid biomarkers for maternal and infant health; Eliana Lucchinetti links omega-3s to gut barrier function; and Helena Fisk studies their role in aging and obesity. Their work is uncovering novel anti-inflammatory pathways, sustainable omega-3 sources (like plant-based ALA and SDA), and strategies to rebalance omega-3/omega-6 ratios-key for women's life-stage wellness.

Brands like Ritual, FullWell, and MegaFood, many founded by women, are translating this research into products tailored to women's needs. Yet, as WIN notes, achieving gender parity in research, innovation, and leadership remains essential.

As we enter the mid-2020s, women-led omega-3 research is driving a paradigm shift: from one-size-fits-all nutrition to precision approaches that honor female biology. For the natural products industry, this means not only meeting the booming demand for women's health products but also centering women in every stage-from lab to leadership-to ensure their health needs are finally, fully met.

References

Omega-3 Research for Women, by Women https://www.nutritionaloutlook.com/view/omega-3-research-for-women-by-women